Vanguard High Dividend Yield ETF (VYM) Stock Price Today
Aura AI Summary
Key Stats
- -Market Cap
- -Volume
- -Sector
- $161.1752W High
- $132.9052W Low
- -Typical Hold Time
- -Enterprise Value
- -Div Yield
- -Trading Activity
Track Vanguard High Dividend Yield ETF (VYM) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Vanguard High Dividend Yield ETF has traded between a low of $132.9 and a high of $161.17, highlighting its annual price range. Buy and sell Vanguard High Dividend Yield ETF shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Vanguard High Dividend Yield ETF
The advisor employs an indexing investment approach designed to track the performance of the index, which consists of common stocks of companies that pay dividends that generally are higher than average. The advisor attempts to replicate the target index by investing all, or substantially all, of the fund's assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Most Recent News
Dimensional Fund Advisors discloses 1.7% stake in Rotork PLC shares.
Dimensional Fund Advisors Ltd has publicly disclosed holding a 1.7% ownership stake in Rotork PLC, amounting to 13,909,604 ordinary shares as of July 16, 2026. This disclosure is made under Rule 8.3 of the Takeover Code, which requires investors with...

Indium Phosphide wafer market to grow to $679.76M by 2035 driven by AI, 5G, and photonics demand
The global Indium Phosphide (InP) wafer market is projected to expand from USD 202.21 million in 2025 to USD 679.76 million by 2035, growing at a CAGR of 12.89%. Growth is fueled by rising demand in AI data centers, 5G and upcoming 6G infrastructure,...

Eli Lilly acquires AtaiBeckley for $3.8B, betting on psychedelic drug for depression.
Eli Lilly has agreed to buy AtaiBeckley for up to $3.8 billion, acquiring a promising psychedelic nasal spray drug, BPL-003, aimed at treating resistant depression. This deal highlights the growing acceptance of psychedelics in medicine, building on ...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.